Your browser doesn't support javascript.
Infection induced SARS-CoV-2 seroprevalence and heterogeneity of antibody responses in a general population cohort study in Catalonia Spain.
Karachaliou, Marianna; Moncunill, Gemma; Espinosa, Ana; Castaño-Vinyals, Gemma; Jiménez, Alfons; Vidal, Marta; Santano, Rebeca; Barrios, Diana; Puyol, Laura; Carreras, Anna; Mayer, Leonie; Rubio, Rocío; Cortés, Beatriz; Pleguezuelos, Vanessa; O'Callaghan-Gordo, Cristina; Fossati, Serena; Rivas, Ioar; Casabonne, Delphine; Vrijheid, Martine; Izquierdo, Luis; Aguilar, Ruth; Basagaña, Xavier; Garcia-Aymerich, Judith; de Cid, Rafael; Dobaño, Carlota; Kogevinas, Manolis.
  • Karachaliou M; Barcelona Institute for Global Health (ISGlobal), 08036, Barcelona, Spain. marianna.karachaliou@isglobal.org.
  • Moncunill G; Barcelona Institute for Global Health (ISGlobal), 08036, Barcelona, Spain.
  • Espinosa A; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
  • Castaño-Vinyals G; Barcelona Institute for Global Health (ISGlobal), 08036, Barcelona, Spain.
  • Jiménez A; Barcelona Institute for Global Health (ISGlobal), 08036, Barcelona, Spain.
  • Vidal M; Barcelona Institute for Global Health (ISGlobal), 08036, Barcelona, Spain.
  • Santano R; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 08036, Madrid, Spain.
  • Barrios D; Barcelona Institute for Global Health (ISGlobal), 08036, Barcelona, Spain.
  • Puyol L; Barcelona Institute for Global Health (ISGlobal), 08036, Barcelona, Spain.
  • Carreras A; Barcelona Institute for Global Health (ISGlobal), 08036, Barcelona, Spain.
  • Mayer L; Barcelona Institute for Global Health (ISGlobal), 08036, Barcelona, Spain.
  • Rubio R; Genomes for Life-GCAT Lab, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain.
  • Cortés B; Barcelona Institute for Global Health (ISGlobal), 08036, Barcelona, Spain.
  • Pleguezuelos V; Barcelona Institute for Global Health (ISGlobal), 08036, Barcelona, Spain.
  • O'Callaghan-Gordo C; Genomes for Life-GCAT Lab, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain.
  • Fossati S; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Rivas I; Barcelona Institute for Global Health (ISGlobal), 08036, Barcelona, Spain.
  • Casabonne D; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 08036, Madrid, Spain.
  • Vrijheid M; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Izquierdo L; Faculty of Health Sciences, Universitat Oberta de Catalunya, Barcelona, Spain.
  • Aguilar R; Barcelona Institute for Global Health (ISGlobal), 08036, Barcelona, Spain.
  • Basagaña X; Barcelona Institute for Global Health (ISGlobal), 08036, Barcelona, Spain.
  • Garcia-Aymerich J; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • de Cid R; Faculty of Health Sciences, Universitat Oberta de Catalunya, Barcelona, Spain.
  • Dobaño C; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 08036, Madrid, Spain.
  • Kogevinas M; Unit of Molecular and Genetic Epidemiology in Infections and Cancer (UNIC-Molecular), Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, Hospitalet De Llobregat, Spain.
Sci Rep ; 11(1): 21571, 2021 11 03.
Article in English | MEDLINE | ID: covidwho-1500510
ABSTRACT
Sparse data exist on the complex natural immunity to SARS-CoV-2 at the population level. We applied a well-validated multiplex serology test in 5000 participants of a general population study in Catalonia in blood samples collected from end June to mid November 2020. Based on responses to fifteen isotype-antigen combinations, we detected a seroprevalence of 18.1% in adults (n = 4740), and modeled extrapolation to the general population of Catalonia indicated a 15.3% seroprevalence. Antibodies persisted up to 9 months after infection. Immune profiling of infected individuals revealed that with increasing severity of infection (asymptomatic, 1-3 symptoms, ≥ 4 symptoms, admitted to hospital/ICU), seroresponses were more robust and rich with a shift towards IgG over IgA and anti-spike over anti-nucleocapsid responses. Among seropositive participants, lower antibody levels were observed for those ≥ 60 years vs < 60 years old and smokers vs non-smokers. Overweight/obese participants vs normal weight had higher antibody levels. Adolescents (13-15 years old) (n = 260) showed a seroprevalence of 11.5%, were less likely to be tested seropositive compared to their parents and had dominant anti-spike rather than anti-nucleocapsid IgG responses. Our study provides an unbiased estimate of SARS-CoV-2 seroprevalence in Catalonia and new evidence on the durability and heterogeneity of post-infection immunity.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Adolescent / Adult / Humans Country/Region as subject: Europa Language: English Journal: Sci Rep Year: 2021 Document Type: Article Affiliation country: S41598-021-00807-4

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Adolescent / Adult / Humans Country/Region as subject: Europa Language: English Journal: Sci Rep Year: 2021 Document Type: Article Affiliation country: S41598-021-00807-4